|
KR102215272B1
(ko)
*
|
2012-09-28 |
2021-02-15 |
이그니타, 인코포레이티드 |
비정형 단백질 키나제 c의 아자퀴나졸린 억제제
|
|
WO2014164543A1
(en)
|
2013-03-13 |
2014-10-09 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
USRE49687E1
(en)
|
2014-09-09 |
2023-10-10 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
WO2016081732A1
(en)
*
|
2014-11-19 |
2016-05-26 |
Memorial Sloan-Kettering Cancer Center |
Thienopyrimidines and uses thereof
|
|
TWI703150B
(zh)
*
|
2015-06-04 |
2020-09-01 |
美商庫拉腫瘤技術股份有限公司 |
用於抑制ｍｅｎｉｎ及ｍｌｌ蛋白之交互作用的方法及組合物
|
|
HK1246593A1
(zh)
*
|
2015-06-04 |
2018-09-14 |
Kura Oncology, Inc. |
用於抑制menin蛋白与mll蛋白的相互作用的方法及组合物
|
|
GB201519573D0
(en)
|
2015-11-05 |
2015-12-23 |
King S College London |
Combination
|
|
US10869868B2
(en)
*
|
2016-01-26 |
2020-12-22 |
Memorial Sloan Kettering Cancer Center |
Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia
|
|
PL3429591T3
(pl)
*
|
2016-03-16 |
2023-07-17 |
Kura Oncology, Inc. |
Podstawione pochodne tieno[2,3-d]pirymidyny jako inhibitory meniny-mll i metody ich zastosowania
|
|
PH12018501955B1
(en)
|
2016-03-16 |
2024-01-24 |
Kura Oncology Inc |
Bridged bicyclic inhibitors of menin-mll and methods of use
|
|
JP6991585B2
(ja)
|
2016-05-02 |
2022-01-12 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
メニン阻害剤としてのピペリジン
|
|
WO2017207387A1
(en)
|
2016-05-31 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Spiro condensed azetidine derivatives as inhibitors of the menin-mml1 interaction
|
|
WO2017214367A1
(en)
*
|
2016-06-10 |
2017-12-14 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of the menin-mll interaction
|
|
WO2018024602A1
(en)
|
2016-08-04 |
2018-02-08 |
Bayer Aktiengesellschaft |
2,7-diazaspiro[4.4]nonanes
|
|
CA3033239A1
(en)
|
2016-09-14 |
2018-03-22 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-mll interaction
|
|
EP3512857B1
(en)
*
|
2016-09-14 |
2021-02-24 |
Janssen Pharmaceutica NV |
Spiro bicyclic inhibitors of menin-mll interaction
|
|
CA3033020A1
(en)
*
|
2016-09-14 |
2018-03-22 |
Janssen Pharmaceutica Nv |
Fused bicyclic inhibitors of menin-mll interaction
|
|
US12084462B2
(en)
|
2016-09-14 |
2024-09-10 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-MLL interaction
|
|
EA039109B1
(ru)
*
|
2016-12-07 |
2021-12-06 |
Кура Онколоджи, Инк. |
Мостиковые бициклические ингибиторы взаимодействия менин-mll и способы применения
|
|
CN110248946B
(zh)
*
|
2016-12-15 |
2023-05-23 |
詹森药业有限公司 |
Menin-MLL相互作用的氮杂环庚烷抑制剂
|
|
WO2018109088A1
(en)
|
2016-12-15 |
2018-06-21 |
Janssen Pharmaceutica Nv |
Azepane inhibitors of menin-mll interaction
|
|
EA038388B1
(ru)
*
|
2017-01-16 |
2021-08-19 |
Кура Онколоджи, Инк. |
Замещенные ингибиторы менина-mll и способы применения
|
|
WO2018175746A1
(en)
*
|
2017-03-24 |
2018-09-27 |
Kura Oncology, Inc. |
Methods for treating hematological malignancies and ewing's sarcoma
|
|
MX2019011412A
(es)
|
2017-03-31 |
2020-02-07 |
Univ Michigan Regents |
Piperidinas como inhibidores de menina covalentes.
|
|
WO2018226976A1
(en)
|
2017-06-08 |
2018-12-13 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
EP3684361A4
(en)
*
|
2017-09-20 |
2021-09-08 |
Kura Oncology, Inc. |
SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHOD OF USING
|
|
JP7307729B2
(ja)
*
|
2017-12-20 |
2023-07-12 |
ヤンセン ファーマシューティカ エヌ．ベー． |
メニン－ｍｌｌ相互作用のエキソ－アザスピロ阻害剤
|
|
US11396517B1
(en)
|
2017-12-20 |
2022-07-26 |
Janssen Pharmaceutica Nv |
Exo-aza spiro inhibitors of menin-MLL interaction
|
|
CN110204552B
(zh)
*
|
2018-02-28 |
2021-08-17 |
中国科学院上海药物研究所 |
一类噻吩并[3,2-d]嘧啶衍生物、其制备方法、药物组合物与用途
|
|
BR112020018094A2
(pt)
|
2018-03-08 |
2020-12-22 |
Incyte Corporation |
Compostos de aminopirazina diol como inibidores de pi3k-¿
|
|
US11325921B2
(en)
|
2018-03-30 |
2022-05-10 |
Sumitomo Dainippon Pharma Co., Ltd. |
Optically active crosslinked cyclic secondary amine derivative
|
|
US11046658B2
(en)
|
2018-07-02 |
2021-06-29 |
Incyte Corporation |
Aminopyrazine derivatives as PI3K-γ inhibitors
|
|
ES2991898T3
(es)
*
|
2018-08-08 |
2024-12-05 |
Sumitomo Pharma Co Ltd |
Derivado de piperidina con puente ópticamente activo
|
|
CA3112340A1
(en)
|
2018-10-03 |
2020-04-09 |
The Regents Of The University Of Michigan |
Small molecule menin inhibitors
|
|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
AU2019395201A1
(en)
*
|
2018-12-06 |
2021-05-20 |
Daiichi Sankyo Company, Limited |
Cycloalkane-1,3-diamine derivative
|
|
WO2020132384A1
(en)
|
2018-12-21 |
2020-06-25 |
Celgene Corporation |
Thienopyridine inhibitors of ripk2
|
|
CN113677341B
(zh)
*
|
2019-02-01 |
2024-07-05 |
南卡罗莱纳大学 |
双环吡啶组合物及其用于癌症治疗的方法
|
|
CA3141826A1
(en)
|
2019-05-31 |
2020-12-03 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
CA3142351A1
(en)
|
2019-05-31 |
2020-12-03 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
CN112116960B
(zh)
*
|
2019-06-20 |
2024-10-11 |
中国石油化工股份有限公司 |
柴油加氢反应的组分含量确定方法、装置
|
|
WO2021067215A1
(en)
|
2019-09-30 |
2021-04-08 |
Agios Pharmaceuticals, Inc. |
Piperidine compounds as menin inhibitors
|
|
UA129778C2
(uk)
|
2019-10-28 |
2025-07-30 |
Мерк Шарп Енд Доум Елелсі |
Низькомолекулярні інгібітори g12c-мутантного kras
|
|
EP4067343A4
(en)
|
2019-11-29 |
2024-01-03 |
Taiho Pharmaceutical Co., Ltd. |
NEW PHENOLIC COMPOUND OR SALT THEREOF
|
|
WO2021106231A1
(en)
*
|
2019-11-29 |
2021-06-03 |
Taiho Pharmaceutical Co., Ltd. |
A compound having inhibitory activity against kras g12d mutation
|
|
TW202525813A
(zh)
|
2019-12-19 |
2025-07-01 |
比利時商健生藥品公司 |
經取代之直鏈螺環接衍生物
|
|
CN111297863B
(zh)
*
|
2020-03-30 |
2021-06-25 |
四川大学华西医院 |
menin-MLL抑制剂在制备治疗子宫内膜癌的药物中的应用
|
|
EP4132932A4
(en)
|
2020-04-07 |
2024-04-17 |
Syndax Pharmaceuticals, Inc. |
COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS OF USE THEREOF
|
|
TW202204333A
(zh)
|
2020-04-08 |
2022-02-01 |
美商阿吉歐斯製藥公司 |
Menin抑制劑及治療癌症之使用方法
|
|
WO2021207310A1
(en)
|
2020-04-08 |
2021-10-14 |
Agios Pharmaceuticals, Inc. |
Menin inhibitors and methods of use for treating cancer
|
|
TW202200589A
(zh)
|
2020-05-28 |
2022-01-01 |
瑞士商諾華公司 |
Ｍｌｌ１抑制劑及抗癌劑
|
|
EP4232020A4
(en)
*
|
2020-10-21 |
2024-08-07 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
|
CA3215379A1
(en)
|
2021-05-08 |
2022-11-17 |
Olivier Alexis Georges Querolle |
Substituted spiro derivatives
|
|
US20240417405A1
(en)
|
2021-05-08 |
2024-12-19 |
Janssen Pharmaceutica Nv |
Substituted Spiro Derivatives
|
|
IL308476A
(en)
|
2021-05-14 |
2024-01-01 |
Syndax Pharmaceuticals Inc |
Inhibitors of the menin-mil interaction
|
|
IL308862A
(en)
|
2021-06-01 |
2024-01-01 |
Janssen Pharmaceutica Nv |
Altered phenyl-1H-pyrrolo[3,2-c]pyridine histories
|
|
JP2024521902A
(ja)
|
2021-06-03 |
2024-06-04 |
ヤンセン ファーマシューティカ エヌ．ベー． |
スピロ環状アミンで置換されたピリダジン又は１，２，４－トリアジン
|
|
WO2022262796A1
(en)
|
2021-06-17 |
2022-12-22 |
Janssen Pharmaceutica Nv |
(r)-n-ethyl-5-fluoro-n-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-m ethylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt for the treatment of diseases such as cancer
|
|
CN115515958B
(zh)
*
|
2021-08-04 |
2023-09-29 |
成都苑东生物制药股份有限公司 |
一种新型磺酰胺类menin-MLL相互作用抑制剂、其制备方法及医药用途
|
|
WO2023011446A1
(zh)
*
|
2021-08-04 |
2023-02-09 |
成都苑东生物制药股份有限公司 |
一种新型磺酰胺类menin-MLL相互作用抑制剂、其制备方法及医药用途
|
|
WO2023056589A1
(en)
|
2021-10-08 |
2023-04-13 |
Servier Pharmaceuticals Llc |
Menin inhibitors and methods of use for treating cancer
|
|
CA3244647A1
(en)
*
|
2021-12-31 |
2025-06-13 |
Hitgen Inc. |
MENINO-MLL INHIBITOR AND ITS USE
|
|
WO2023215354A1
(en)
*
|
2022-05-03 |
2023-11-09 |
Board Of Regents, The University Of Texas System |
Menin proteolysis targeting chimeras (protacs)
|
|
CN120529900A
(zh)
|
2022-11-24 |
2025-08-22 |
奥莱松基因组股份有限公司 |
用于治疗癌症的LSD1抑制剂和Menin抑制剂的组合
|
|
CN116199633B
(zh)
*
|
2022-12-27 |
2024-05-31 |
甘肃省化工研究院有限责任公司 |
一种制备瑞维鲁胺的方法
|
|
AU2024361909A1
(en)
|
2023-10-20 |
2026-03-26 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|